store at low temperature
store at -20°C
Bococizumab(PF-04950615) is a humanized mAb against PCSK9 and an inhibitor of the synthesis of PCSK9 in the liver that reduces the amount of low-density lipoprotein cholesterol (LDL-C) in the blood.Bococizumab is used to treat hypercholesterolemia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 347.00 | |
5 mg | In stock | $ 872.00 | |
10 mg | In stock | $ 1,390.00 | |
25 mg | In stock | $ 1,980.00 | |
50 mg | In stock | $ 2,780.00 | |
100 mg | In stock | $ 3,750.00 |
Description | Bococizumab(PF-04950615) is a humanized mAb against PCSK9 and an inhibitor of the synthesis of PCSK9 in the liver that reduces the amount of low-density lipoprotein cholesterol (LDL-C) in the blood.Bococizumab is used to treat hypercholesterolemia. |
In vivo | Bococizumab (0, 10, 30, and 100 mg/kg; i.v.; Pregnant Sprague-Dawley (SD) rats) decreases maternal and fetal cholesterol and shows good tolerance and no effects on ovarian or uterine parameters.[2] |
Synonyms | RN316, PF-04950615 |
Molecular Weight | N/A |
CAS No. | 1407495-02-6 |
store at low temperature
store at -20°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bococizumab 1407495-02-6 Others RN316 PF 04950615 RN-316 PF-04950615 PF04950615 RN 316 inhibitor inhibit